2SLS estimates with both firm and year fixed effects
| First-stage regression | Second-stage regression | |||
|---|---|---|---|---|
| Variables | Audit committee independence as dependent variable | (1)ESG_SCORE | (2)ESG_COMB | (3)ESG_EVE |
| AC_MGT | 11.4520*** (3.539) | |||
| AC_IND | 0.0156*** (3.136) | 0.0149*** (2.636) | 0.0175*** (3.234) | |
| −0.0453 (−0.710) | 0.0036*** (3.067) | 0.0040*** (3.305) | 0.0040*** (3.201) | |
| 0.5214 (0.220) | −0.1659** (−2.177) | −0.1729** (−2.331) | −0.1978** (−2.263) | |
| −5.2737 (−1.368) | 0.1287 (1.633) | 0.1483* (1.880) | 0.1203 (1.424) | |
| 5.2444*** (3.472) | 0.0783** (2.002) | 0.0916** (2.146) | 0.0835** (1.974) | |
| 2.1376 (1.135) | −0.0515 (−1.261) | −0.0173 (−0.344) | −0.0604 (−1.435) | |
| 1.3787*** (3.907) | −0.0111 (−0.976) | −0.0128 (−1.046) | −0.0148 (−1.170) | |
| −0.1504 (−0.539) | −0.0028 (−0.558) | 0.0013 (0.180) | −0.0036 (−0.648) | |
| Firm fixed effects | Yes | Yes | Yes | Yes |
| Year fixed effects | Yes | Yes | Yes | Yes |
| Observations | 1,156 | 1,156 | 1,156 | 1,156 |
| Number of firms | 261 | 261 | 261 | 261 |
| First-stage F-test of excluded instruments | 12.53 | |||
| Endogeneity test (chi-stat) | 10.847*** | 7.020*** | 11.769*** | |
| Cragg–Donald Wald F-statistic | 29.32 | 29.32 | 29.32 | |
| Second-stage F-statistic | 19.65 | 15.24 | 19.66 | |
| First-stage regression | Second-stage regression | |||
|---|---|---|---|---|
| Variables | Audit committee independence as dependent variable | (1)ESG_SCORE | (2)ESG_COMB | (3)ESG_EVE |
| 11.4520 | ||||
| 0.0156 | 0.0149 | 0.0175 | ||
| −0.0453 (−0.710) | 0.0036 | 0.0040 | 0.0040 | |
| 0.5214 (0.220) | −0.1659 | −0.1729 | −0.1978 | |
| −5.2737 (−1.368) | 0.1287 (1.633) | 0.1483 | 0.1203 (1.424) | |
| 5.2444 | 0.0783 | 0.0916 | 0.0835 | |
| 2.1376 (1.135) | −0.0515 (−1.261) | −0.0173 (−0.344) | −0.0604 (−1.435) | |
| 1.3787 | −0.0111 (−0.976) | −0.0128 (−1.046) | −0.0148 (−1.170) | |
| −0.1504 (−0.539) | −0.0028 (−0.558) | 0.0013 (0.180) | −0.0036 (−0.648) | |
| Firm fixed effects | Yes | Yes | Yes | Yes |
| Year fixed effects | Yes | Yes | Yes | Yes |
| Observations | 1,156 | 1,156 | 1,156 | 1,156 |
| Number of firms | 261 | 261 | 261 | 261 |
| First-stage | 12.53 | |||
| Endogeneity test (chi-stat) | 10.847 | 7.020 | 11.769 | |
| Cragg–Donald Wald | 29.32 | 29.32 | 29.32 | |
| Second-stage | 19.65 | 15.24 | 19.66 | |
Note(s): Robust z-statistics in parentheses. *, ** and *** represent significant at the 10, 5 and 1% level, respectively
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.